Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 2,521

Document Document Title
WO/2006/125295A1
The present invention provides new derivatives of 4-or 5-aminosalicylic acid, and a pharmaceutical composition containing these derivatives of 4-or 5-aminosalicylic acid as active ingredients, useful for the treatment of intestinal disea...  
WO/2006/126415A1
A sulfur-containing cycloolefin resin of 1000 to 1,000,000 weight average molecular weight comprised of any of units of the general formula (1): wherein each of R1 to R6 independently is a hydrogen atom, a C1-C20 alkyl, a C1-C20 aralkyl,...  
WO2006079112A3
This invention provides a method of synthesizing enantioenriched merrilactone A and enantiopure merrilactone A, as well as an improved method of synthesizing racemic merrilactone. This invention also provides intermediate compounds and m...  
WO/2006/125293A1
The present invention provides new derivatives of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these derivatives of 4- or 5-aminosalicylic acid as active ingredients, useful for the treatment of intestinal dis...  
WO/2006/119758A2
The invention relates to dihydroxyphenylalanine derivatives, the production thereof, and pharmaceutical compositions containing said dihydroxyphenylalanine derivatives. The invention further relates to the use of said dihydroxyphenylalan...  
WO/2006/117995A1
A therapeutic agent for loss of scalp hair comprising a lipoic acid or a lipoic acid derivative represented by the formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient: (1) wherein R represents an OH group, a...  
WO2006036941A3
Resorcylic acid lactones having a C5-C6 cis double bond and a ketone at C7 and other compounds capable of Michael adduct formation are potent and stable inhibitors of a subset of protein kinases having a specific cysteine residue in the ...  
WO2006089861A3
The invention relates to dithiolethiones derivatives as monoamino oxidase inhibitors, in particular MAO-B inhibitors, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said dithiolet...  
WO/2006/111791A1
The present invention relates to novel non steroidal anti-inflammatory compounds (NSAIDs) that release hydrogen sulfide (H2S). The present invention also provides methods for treating, preventing and/or reducing inflammation-associated d...  
WO/2006/110221A1
Various non-limiting embodiments disclosed herein relate to photochromic materials having extended pi-conjugated systems. For example, various non-limiting embodiments disclosed herein provide a photochromic material, such as an indeno-f...  
WO2006014219A3
A process for the manufacture of new stable, crystalline salts of N-[2-(dimethylamino)-ethyl]-1,2-dithiolane-3-pentanamide (racemic and chiral forms) with good water solubility that are useful as antioxidant compounds and effectively inh...  
WO/2006/100229A1
Process for purifying thioctic acid in water comprising the following steps: a) dissolving the thioctic acid in an aqueous alkaline solution or alternatively dissolving a thioctic acid salt, if necessary adjusting the pH to alkaline valu...  
WO2005037257A3
The invention relates to medicinally used substances which specifically inhibit peptidases splitting ala-p-nitroanilide. The invention further relates to the use of at least one such substance or at least one pharmaceutical or cosmetic c...  
WO2005075453A9
A novel linker compound that minimizes any nonspecific hydrophobic interactions and is capable of easily regulating the length to disulfide group subjected to metal bond to thereby enable efficient formation of metal-sulfur bond; a novel...  
WO/2006/089861A2
The invention relates to dithiolethiones derivatives as monoamino oxidase inhibitors, in particular MAO-B inhibitors, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said dithiolet...  
WO2006028977A3
The present invention provides a chiral ligand, represented by a formula or its enantiomer: formula (I) X and X' can be independently O, NH, NR, NCOR or S; each of Z1-Z7 and Z1'-Z7' can be independently H, alkyl, aryl, substituted alkyl,...  
WO/2006/085510A1
A remedy for IBS comprising, as the active ingredient, a dual antagonist for 5-HT2B and 5-HT7 receptors which shows selective binding affinities to 5-HT2B and 5-HT7 receptors. The above-described medicinal composition is superior in the ...  
WO2004078908A3
The present invention relates to novel a-keto carbonyl calpain inhibitors for the treatment of neurodegenerative diseases and neuromuscular diseases including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and other muscular dyst...  
WO/2006/066894A1
Compounds of general formula (I), wherein R’, R, x and z have the meaning reported in the specification, are useful for treating inflammatory diseases including metabolic syndrome, diabetes, obesity, dyslipidemia, and insulin resistance.  
WO2006047011A3
Fuels, especially hydrocarbon fuels, and lubricants, especially lubricating oils, contain a class of anti-corrosion, anti-wear, anti-fatigue, and extreme pressure additives that are derived from 1,3-dithiolane-2-thiones.  
WO2006048911A3
Compositions to be incorporated in products with hypoglycemizing, anti-oxidant, vasoprotective and anti-hyperlipemic activity, or in products recommended for the treatment of anaemias and states or iron deficiency, the compositions being...  
WO2006044379A3
The present invention relates to compounds capable of acting as androgen receptor, antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agen...  
WO/2006/048911A2
Compositions to be incorporated in products with hypoglycemizing, anti-oxidant, vasoprotective and anti-hyperlipemic activity, or in products recommended for the treatment of anaemias and states or iron deficiency, the compositions being...  
WO/2006/047011A2
Fuels, especially hydrocarbon fuels, and lubricants, especially lubricating oils, contain a class of anti-corrosion, anti-wear, anti-fatigue, and extreme pressure additives that are derived from 1,3-dithiolane-2-thiones.  
WO/2006/044379A2
The present invention relates to compounds capable of acting as androgen receptor, antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agen...  
WO/2006/029532A1
Nitrate esters and methods for mitigating neurodegeneration, affecting neuroprotection, affecting cognition enhancement, and/or preventing or mitigating tissue and/or cellular damage in a subject are described. Neurological or cognitive ...  
WO/2006/021282A1
The invention relates to novel compounds containing at least one multiple bond that is excited by irradiation with polarised light and thus produces an anisotropy in films containing said compounds or amplifies an already existing anisot...  
WO/2006/021413A1
The present invention relates to novel &agr -keto carbonyl calpain inhibitors for the treatment of neurodegenerative diseases and neuromuscular diseases including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and other muscular ...  
WO2005079378A3
Synthetic methods and intermediates useful in the preparation of lactone containing compounds such as discodermolide and compounds which mimic the chemical or biological activity of discodermolide are provided.  
WO/2006/014219A2
A process for the manufacture of new stable, crystalline salts of N-[2-(dimethylamino)-ethyl]-1,2-dithiolane-3-pentanamide (racemic and chiral forms) with good water solubility that are useful as antioxidant compounds and effectively inh...  
WO2002046150A3
Compounds which mimic the chemical and/or biological activity of discodermolide are provided and intermediates useful in their preparation.  
WO/2005/095941A1
A mass analysis method for a derivative of an organic residue containing a sulfur atom, characterized in that it comprises ionizing a derivative of an organic residue containing said sulfur atom from a metal-organic residue composite whe...  
WO/2005/085186A1
Disclosed is a method for producing an isocyanate compound through reaction between a carbonate of a corresponding amine compound and phosgene, wherein phosgene is introduced into an organic solvent solution of the carbonate of the amine...  
WO/2005/079845A1
Preventives for migraine which contain, as the active ingredient, a double antagonist to 5-HT2B and 5-HT7 receptors having selective binding affinities for the 5-HT2B and 5-HT7 receptors. These preventives for migraine show a favorable p...  
WO/2005/080322A1
A novel fluorene characterized by having a fluorene skeleton to which a functional group such as a guanidino group is attached via a carbonyl group, or its salt. This compound has such an advantage as showing a high affinity particularly...  
WO/2005/079378A2
Synthetic methods and intermediates useful in the preparation of lactone containing compounds such as discodermolide and compounds which mimic the chemical or biological activity of discodermolide are provided.  
WO/2005/075453A1
A novel linker compound that minimizes any nonspecific hydrophobic interactions and is capable of easily regulating the length to disulfide group subjected to metal bond to thereby enable efficient formation of metal-sulfur bond; a novel...  
WO/2005/073184A1
The invention relates to substituted 1,3-diphenylprop-2-en-1-one derivative compounds, pharmaceutical and/or cosmetic compositions containing same, and the applications thereof in therapeutics and cosmetics. The invention also relates to...  
WO/2005/068415A1
Disclosed is a phenylalanine derivative having excellent VLA-4 inhibitory activity which is represented by the following general formula (1) or a salt thereof. (1) (In the formula, R1 represents an aromatic hydrocarbon group having 6-10 ...  
WO/2005/051941A1
A 1,2,4-triazole derivative of formula (1) or a non-toxic salt thereof, a preparation method thereof, and a pharmaceutical composition containing the derivative or the salt as an active ingredient are provided.  
WO/2005/049741A1
A method of forming a SAM on at least one surface of a substrate by application to said surface of a 2-mono-, or 2,2-disubstituted 1,3-dithiacyclopentane so as to form a SAM prepared therefrom on said surface.  
WO/2005/043962A1
Disclosed is a charge-transporting organic material which contains a compound with a 1,4-dithiin ring which is represented by the formula (1) below. By using a thin film made of such a organic material in a small-molecule organic electro...  
WO/2005/037257A2
The invention relates to medicinally used substances which specifically inhibit peptidases splitting ala-p-nitroanilide. The invention further relates to the use of at least one such substance or at least one pharmaceutical or cosmetic c...  
WO2004098582A3
The present invention pertains to certain ketones and reduced ketones and derivatives thereof which, inter alia, inhibit osteoclast survival, formation, and/or activity; and/or inhibit bone resorption, and more particularly to compounds ...  
WO/2005/019159A1
A process for producing corresponding &agr -aminooxyketones in high yield and with high enantioselectivity, that is, a process for the production of optically active &agr -aminooxyketone derivatives represented by the general formula (1)...  
WO2004077511A3
The present invention provides novel (meth)acrylic and (meth)acrylamide monomers and polymers produced from those monomers. The monomers of the invention each include only a single vinyl functionality and at least one non-vinyl functiona...  
WO2004069774A3
There is provided a method of producing novel <13>C-labelled estrogen analogues. The method preferably proceeds via an intermediate A or B or which is a mixture of (A) or (B): wherein a <13>C atom is located at one or more of positions 1...  
WO2004002940A8  
WO2004052316A3
Compounds of formula (I), process for making the same, and cosmetic compositions and methods of skin lightening using compounds of formula (I) as skin lightening agents: (I) wherein each A1 and/or A2 independently is = H or COR, CO2R, CO...  
WO/2004/099162A1
Compounds of Formula 8 are provided: A and B are each independently selected from the group consisting of -NO-, -SO-, and - NR9-. C is a single bond or a double bond. D is selected from the group consisting of single bond, E is selected ...  

Matches 201 - 250 out of 2,521